Acetylcholinesterase inhibitors and Gulf War illnesses

Proceedings of the National Academy of Sciences of the United States of America

Volumn 105, Issue 11, 2008, Pages 4295-4300

  Golomb, Beatrice Alexandra ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Gulf War veteran; Organophosphate; Pesticide; Pyridostigmine; Sarin

Indexed keywords

CARBAMIC ACID; CHOLINESTERASE INHIBITOR; ORGANOPHOSPHATE; PESTICIDE; PYRIDOSTIGMINE; ARYLDIALKYLPHOSPHATASE; CHOLINESTERASE;

ARTICLE; CONCENTRATION (PARAMETERS); DETOXIFICATION; DOSE RESPONSE; ENZYME ACTIVITY; GENERAL ASPECTS OF DISEASE; GENOTYPE; HUMAN; OCCUPATIONAL EXPOSURE; PILL; PRIORITY JOURNAL; VETERAN; WAR; CHEMICALLY INDUCED DISORDER; ENZYMOLOGY; GENETICS; METABOLISM; OCCUPATIONAL DISEASE;

ARYLDIALKYLPHOSPHATASE; BUTYRYLCHOLINESTERASE; CHOLINESTERASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; GULF WAR; HUMANS; OCCUPATIONAL DISEASES; VETERANS;

EID: 41949132813     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0711986105     Document Type: Article

References (72)

1. Steele L (2000) Prevalence and patterns of Gulf War illness in Kansas veterans: association of symptoms with characteristics of person, place, and time of military service. Am J Epidemiol 152:992-1002.
2. Fukuda K, et al. (1998) Chronic multisymptom illness affecting Air Force veterans of the Gulf War. J Am Med Assoc 280:981-988.
3. Iowa Persian Gulf Study Group (1997) Self-reported illness and health status among Gulf War veterans: A population-based study. J Am Med Assoc 277:238-245.
4. Unwin C, et al. (1999) Health of UK servicemen who served in the Persian Gulf War. Lancet 353:169-178.
5. Haley R (1998) Point: bias from the "healthy-warrior effect" and unequal follow-up in three government studies of health effects of the Gulf War. Am J Epidemiol 148:315-323.
6. White RF (2003) Service in the Gulf War and significant health problems: focus on the central nervous system. J Psychopathol Behav Assess 25:77-83.
7. Hotopf M, et al. (2003) Gulf War illness- better, worse, or just the same? A cohort study. Brit Med J 327:1370.
8. Kroenke K, Koslowe P, Roy M (1998) Symptoms in 18,495 Persian Gulf War veterans. Latency of onset and lack of association with self-reported exposures. J Occ Environ Med 40:520-528.
9. Golomb BA (1999) A Review of the Scientific Literature as It Pertains to Gulf War Illnesses (RAND, Santa Monica, CA), Vol 2.
10. US Department of Defense (2003) Environmental Exposure Report. Pesticides. Final Report. Available at http://www.gao.gov/htext/d04159.html. Accessed May 28, 2007.
11. Fricker RD, et al. (2000) A Review of the Scientific Literature as It Pertains to Gulf War Illnesses (RAND, Santa Monica, CA), Vol 12.
12. Berardocco D (1997) DoD, CIA release Khamisiyah modeling data. GulfNEWS 1:3.
13. US General Accounting Office (2004) Gulf War Illnesses: DOD's Conclusions about US Troops' Exposure Cannot Be Adequately Supported. GAO report number GAO-04-159. Available at http://www.gao.gov/htext/d04159.html. Accessed June 1, 2004.
14. Cecchine G, Golomb B, Hilborne LH, Spektor DM, Anthony CR (2000) A Review of the Scientific Literature as it Pertains to Gulf War Illnesses (RAND, Washington, DC), Vol 8.
15. Commonwealth Department of Veterans' Affairs (2003) Australian Gulf War Veterans' Health Study. Available at www.dva.gov.au/media/publicat/2003/ gulfwarhs/html/executive_summary.htm. Accessed February 20, 2008.
16. Bell IR, Warg-Damiani L, Baldwin CM, Walsh ME, Schwartz GE (1998) Self-reported chemical sensitivity and wartime chemical exposures in Gulf War veterans with and without decreased global health ratings. Mil Med 163:725-732.
17. Cherry N, et al. (2001) Health and exposures of United Kingdom Gulf War veterans. Part II: The relation of health to exposure. Occup Environ Med 58:299-306.
18. Gray GC, Reed RJ, Kaiser KS, Smith TC, Gastanaga VM (2002) Self-reported symptoms and medical conditions among 11,868 Gulf War-era veterans: the Seabee Health Study. Am J Epidemiol 155:1033-1044.
19. Haley RW, Kurt TL, Hom J (1997) Is there a Gulf War Syndrome? Searching for syndromes by factor analysis of symptoms. J Am Med Assoc 277:215-222.
20. Kang HK, Mahan CM, Lee KY, Magee CA, Murphy FM (2000) Illnesses among United States veterans of the Gulf War: a population-based survey of 30,000 veterans. J Occup Environ Med 42:491-501.
21. Kang H, et al. (2002) Evidence for a deployment-related Gulf War syndrome by factor analysis. Arch Environ Health 57:61-68.
22. McCauley LA, et al. (2001) Symptoms of Gulf War veterans possibly exposed to organophosphate chemical warfare agents at Khamisiyah, Iraq. Int J Occup Environ Health 7:79-89.
23. McCauley L, Lasarev M, Sticker D, Rischitelli D, Spencer P (2002) Illness experience of Gulf War veterans possibly exposed to chemical warfare agents. Am J Prev Med 23:200.
24. Nisenbaum R, Barrett DH, Reyes M, Reeves WC (2000) Deployment stressors and a chronic multisymptom illness among Gulf War veterans. J Nerv Ment Dis 188:259-266.
25. Proctor SP, et al. (1998) Health status of Persian Gulf War veterans: self-reported symptoms, environmental exposures and the effect of stress. Int J Epidemiol 27:1000-1010.
26. Proctor SP, Erickson D, Huang M, Hu H, Wolfe J (1999) Conference on Federally Sponsored Gulf War Veterans' Illnesses Research Program and Abstrat Book (Persian Gulf Veterans Coordinating Board, Arlington, VA), p 34 (abstr).
27. Proctor SP, Harley R, Wolfe J, Heeren T, White RF (2001) Health-related quality of life in Persian Gulf War Veterans. Mil Med 166:510-519.
28. Schumm WR, et al. (2001) Pyridostigmine bromide and the long-term subjective health status of a sample of female reserve component Gulf War veterans: A brief report. Psychol Rep 88:306-308.
29. Schumm WR, et al. (2002) Pyridostigmine bromide and the long-term subjective health status of a sample of over 700 male Reserve Component Gulf War era veterans. Psychol Rep 90:707-721.
30. Spencer PS, et al. (2001) Self-reported exposures and their association with unexplained illness in a population-based case-control study of Gulf War veterans. J Occup Environ Med 43:1041-1056.
31. Sullivan K, et al. (2003) Cognitive functioning in treatment seeking Gulf War veterans: Pyridostigmine use and PTSD. J Psychopathol Behav Assess 25:95-103.
32. White RF, et al. (2001) Neuropsychological function in Gulf War veterans: relationships to self-reported toxicant exposures. Am J Ind Med 40:42-54.
33. Wolfe J, Proctor SP, Erickson DJ, Hu H (2002) Risk factors for multisymptom illness in US Army veterans of the Gulf War. J Occup Environ Med 44:271-281.
34. Reid S, et al. (2001) Multiple chemical sensitivity and chronic fatigue syndrome in British Gulf War veterans. Am J Epidemiol 153:604-609.
35. Haley RW, Kurt TL (1997) Self-reported exposure to neurotoxic chemical combinations in the Gulf War: A cross-sectional epidemiologic study. J Am Med Assoc 277:231-237.
36. Department of Defense (2001) DoD assessments for events at Al Jubayl remain unchanged. Available at www.gulflink.osd.mil/news/ na_al_jubayl_22feb01.htm. Accessed May 29, 2007.
37. Siegel S, Castellan NJ (1988) Nonparametric Statistics for the Behavioral Sciences (McGraw-Hill, New York).
38. Proctor SP, Heaton KJ, Heeren T, White RF (2006) Effects of sarin and cyclosarin exposure during the 1991 Gulf War on neurobehavioral functioning in US army veterans. Neurotoxicology 27:931-939.
39. Heaton KJ, et al. (2007) Quantitative magnetic resonance brain imaging in US army veterans of the 1991 Gulf War potentially exposed to sarin and cyclosarin. Neurotoxicology 28:761-769.
40. Haley RW, Billecke S, La Du BN (1999) Association of low PON1 type Q (type A) arylesterase activity with neurologic symptom complexes in Gulf War veterans. Toxicol Appl Pharmacol 157:227-233.
41. Mackness B, Durrington PN, Mackness MI (2000) Low paraoxonase in Persian Gulf War Veterans self-reporting Gulf War Syndrome. Biochem Biophys Res Commun 276:729-733.
42. Hotopf M, et al. (2003) Paraoxonase in Persian Gulf War veterans. J Occup Environ Med 45:668-675.
43. Doctor BP, Saxena A (2005) Bioscavengers for the protection of humans against organophosphate toxicity. Chem Biol Interact 157-158:167-171.
44. Lockridge O (1999) Butyrylcholinesterase genetic variants in persons with Gulf War illness. Available at www.gulflink.osd.mil/medsearch/ GeneticStudies/DoD60.shtml. Accessed February 20, 2008.
45. Wessa P (2008) Kendall tau rank correlation. Available at http://wessa.net. Accessed February 20, 2008.
46. Davies DR, Ahmed GM, Freer T (1999) Chronic organophosphate induced neuropsychiatric disorder (COPIND): results of two postal questionnaire surveys. J Nutral Environ Med 9:123-134.
47. Bazylewicz-Walczak B, Majczakowa W, Szymczak M (1999) Behavioral effects of occupational exposure to organophosphorous pesticides in female greenhouse planting workers. Neurotoxicology 20:819-826.
48. Cherry N, et al. (2002) Paraoxonase (PON1) polymorphisms in farmers attributing ill health to sheep dip. Lancet 359:763-764.
49. Khan F, Kennedy G, Spence VA, Newton DJ, Belch JJ (2004) Peripheral cholinergic function in humans with chronic fatigue syndrome, Gulf War syndrome and with illness following organophosphate exposure. Clin Sci (London) 106:183-189.
50. Miyaki K, et al. (2005) Effects of sarin on the nervous system of subway workers seven years after the Tokyo subway sarin attack. J Occup Health 47:299-304.
51. Rohlman DS, et al. (2007) Neurobehavioral performance of adult and adolescent agricultural workers. Neurotoxicology 28:374-380.
52. Abu-Qare AW, Abou-Donia MB (2002) Sarin: health effects, metabolism, and methods of analysis. Food Chem Toxicol 40:1327-1333.
53. Henderson RF, et al. (2001) Response of F344 rats to inhalation of subclinical levels of sarin: exploring potential causes of Gulf War illness. Toxicol Ind Health 17:294-297.
54. Henderson RF, et al. (2002) Response of rats to low levels of sarin. Toxicol Appl Pharmacol 184:67-76.
55. Stone JD, Terry AV, Jr, Pauly JR, Prendergast MA, Buccafusco JJ (2000) Protractive effects of chronic treatment with an acutely sub-toxic regimen of diisopropylflurophosphate on the expression of cholinergic receptor densities in rats. Brain Res 882:9-18.
56. Kaufer D, Friedman A, Seidman S, Soreq H (1998) Acute stress facilitates long-lasting changes in cholinergic gene expression. Nature 393:373-377.
57. Lev-Lehman E, et al. (2000) Synaptogenesis and myopathy under acetylcholinesterase overexpression. J Mol Neurosci 14:93-105.
58. Brenner T, et al. (2003) The role of readthrough acetylcholinesterase in the pathophysiology of myasthenia gravis. FASEB J 17:214-222.
59. Kaufer D, Friedman A, Seidman S, Soreq H (1999) Anticholinesterases induce multigenic transcriptional feedback response suppressing cholinergic neurotransmission. Chem Biol Interact 119-120:349-360.
60. Li L, Shou Y, Borowitz JL, Isom GE (2001) Reactive oxygen species mediate pyridostigmine-induced neuronal apoptosis: involvement of muscarinic and NMDA receptors. Toxicol Appl Pharmacol 177:17-25.
61. Li L, Gunasekar PG, Borowitz JL, Isom GE (2000) Muscarinic receptor-mediated pyridostigmine-induced neuronal apoptosis. Neurotoxicology 21:541-552.
62. Kassa J, Skopec F, Vachek J (2000) The long-term changes in liver DNA, total protein contents following low level sarin exposure in rats. Acta Medica (Hradec Kralove) 43:19-22.
63. Damodaran TV, et al. (2006) Gene expression profiles of the rat brain both immediately and 3 months following acute sarin exposure. Biochem Pharmacol 71:497-520.
64. Haley RW (2003) Excess incidence of ALS in young Gulf War veterans. Neurology 61:750-756.
65. Weisskopf MG, et al. (2005) Prospective study of military service and mortality from ALS. Neurology 64:32-37.
66. Morahan JM, Pamphlett R (2006) Amyotrophic lateral sclerosis and exposure to environmental toxins: an Australian case-control study. Neuroepidemiology 27:130-135.
67. Saeed M, et al. (2006) Paraoxonase cluster polymorphisms are associated with sporadic ALS. Neurology 67:771-776.
68. Morahan JM, Yu B, Trent RJ, Pamphlett R (2007) A gene-environment study of the paraoxonase 1 gene and pesticides in amyotrophic lateral sclerosis. Neurotoxicology 28:532-540.
69. Stephenson J (2000) Exposure to home pesticides linked to Parkinson disease. J Am Med Assoc 283:3055-3056.
70. Tuchsen F, Jensen AA (2000) Agricultural work and the risk of Parkinson's disease in Denmark, 1981-1993. Scand J Work Environ Health 26:359-362.
71. Benmoyal-Segal L, et al. (2005) Acetylcholinesterase/paraoxonase interactions increase the risk of insecticide-induced Parkinson's disease. FASEB J 19:452-454.
72. Zintzaras E, Hadjigeorgiou GM (2004) Association of paraoxonase 1 gene polymorphisms with risk of Parkinson's disease: a meta-analysis. J Hum Genet 49:474-481.